Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00841256|
Recruitment Status : Completed
First Posted : February 11, 2009
Last Update Posted : October 16, 2015
|Condition or disease||Intervention/treatment||Phase|
|Allergic Rhinoconjunctivitis||Biological: Grass pollen allergens in a water/glycerol solution Drug: Placebo||Phase 3|
Although highly effective, subcutaneous administration of allergens may cause inconvenience in some patients. Alternative routes, e.g. nasal and oral, have therefore been investigated to find an immunotherapy regimen largely accepted by all groups of patients, including children.
Sublingual specific immunotherapy (SLIT) may represent a more acceptable route of immunotherapy. It may be an optimal therapy option especially for children because they often fear injections.
In this study children are to be treated with a preparation of a grass pollen allergen extract in a water/glycerol solution with phosphate buffered saline in comparison to a symptomatic standard treatment with add on placebo, in order to investigate efficacy and safety of the study drug.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||207 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|
|Official Title:||... Study to Evaluate Efficacy and Safety of Perennial Sublingual SIT With a Solution of Grass Pollen Allergen ... in Children With Clinically Relevant Grass Pollen Sensitivity in Comparison to a ... Standard Treatment With Add on Placebo|
|Study Start Date :||February 2008|
|Primary Completion Date :||June 2012|
|Study Completion Date :||August 2015|
Grass pollen allergens in a water/glycerol solution
Biological: Grass pollen allergens in a water/glycerol solution
In total up to 4 drops (dose for maintenance therapy) are administered under the tongue.
Other Name: Allerslit forte grasses
Placebo Comparator: Placebo
Water/glycerol solution with phosphate buffered saline
Placebo was given in the same way as the sublingual active treatment. Symptomatic standard treatment, i.e. antihistamines and glucocorticoids as well as alphamimetics is allowed during grass pollen season.
Other Name: Comparator
- Changes of Symptom-Medication-Score [ Time Frame: After 1 year of treatment ]The change of the area under the curve of the symptom and medication score (SMS) from the baseline season to the season after 1 year of treatment.
- Evaluation of the documentation of adverse events (AEs) [ Time Frame: Entire treatment period ]Safety of treatments during the entire treatment period.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00841256
|Klinik für Paediatrie Universitätsmedizin Berlin|
|Berlin, Germany, 13353|
|Principal Investigator:||Ulrich Wahn, MD||Charite University, Berlin, Germany|